Seres Therapeutics, Inc. MCRB
1.70 USD -0.28 (-14.14%)
At closeNov 9, 2026, 4:00 PM EST
1.80 +0.10 +5.88%
After hours · Nov 9, 4:00 PM ET
1.69 Day range 2.05
1.68 52-week range 29.98
- YTD
- -88.58%
- 1 year
- -87.87%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 789.00K | 0 | 0 | 0 | 144.93M | |
| 789.00K | 0 | 0 | 0 | 144.93M | |
| -93.97M | -121.31M | -195.10M | -179.91M | -64.49M | |
| 5.70M | 136.00K | -113.72M | -250.16M | -65.58M | |
| 0.64 | — | -17.77 | -46.20 | -14.40 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 54.43M | 39.46M | 136.15M | 171.22M | 188.00M | |
| 138.19M | 139.81M | 358.60M | 348.78M | 354.86M | |
| 93.97M | 126.03M | 403.46M | 338.00M | 223.35M | |
| 82.97M | 91.64M | 198.78M | 162.59M | 49.21M | |
| 44.22M | 13.78M | -44.86M | 10.78M | 131.51M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.12M | -148.61M | -117.35M | -228.82M | 6.69M | |
| -42.00K | 142.29M | 10.58M | 82.43M | 64.09M | |
| 13.90M | -90.37M | 71.70M | 129.60M | 1.18M | |
| -42.00K | -380.00K | -7.97M | -9.82M | -9.57M | |
| 14.97M | -96.69M | -35.07M | -16.79M | 71.95M |